Kettlewell, Brenna
Armstrong, Andrea
Levin, Kirill
Salem, Riad
Kim, Edward
Lewandowski, Robert J.
Loizides, Alexander
Abraham, Robert J.
Boyd, Daniel
Article History
Received: 30 April 2025
Accepted: 15 July 2025
First Online: 28 July 2025
Declarations
:
: B. Kettlewell, D. Boyd and A. Armstrong are holders of the intellectual property described in this work and are co-founders of Synergy Oncology Inc. R. Abraham is a previous employee and current shareholder in ABK Biomedical Inc. R. Lewandowski, E. Kim, and R. Salem are advisors to Synergy Oncology Inc. and Boston Scientific. R. Lewandowski is also an advisor for Sirtex and ABK Biomedical Inc. K. R. Salem is also an advisor for Cook Medical, AstraZeneca, Siemens, Genentech, Terumo, Eisai, Becton Dickinson, Trisalus, and Sirtex. Levin and A. Loizides have no relevant financial or non-financial interests to disclose.